GLP-1 Receptor Agonists in Acute Ischemic Stroke and Secondary Stroke Prevention: A Narrative Review of Preclinical and Clinical Evidence
GLP-1 drugs used for diabetes may help prevent strokes, revealing an unexpected benefit as stroke prevention research expands.
This narrative review examines the potential role of GLP-1 receptor agonists in acute ischemic stroke and secondary stroke prevention, drawing on preclinical mechanistic and clinical trial data. The review highlights an emerging indication for GLP-1 agents in cerebrovascular disease relevant to the rapidly expanding therapeutic landscape.
What the study was
- Study design
- Narrative review
- Population
- Ischemic stroke patients and at-risk populations
- Category
- Treatment Innovation
- Maturity
- Exploratory
- Journal
- Journal of Central Nervous System Disease
Why it surfaced
Narrative review only; emerging GLP-1 stroke indication is relevant to cardiometabolic watchlist but design quality is low.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.